Gene · 1024
Papers2,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 2,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Frequent Genetic Alterations and Their Clinical Significance in Patients With Thymic Epithelial Tumors. | Front Oncol | 2021 | 34307137 | PubTator, text mining | PubMed |
| [Corrigendum] miR‑592 acts as an oncogene and promotes medullary thyroid cancer tumorigenesis by targeting cyclin‑dependent kinase 8. | Mol Med Rep | 2021 | 34296311 | PubTator, text mining | PubMed |
Circular RNA FAT atypical cadherin 1 (circFAT1)/microRNA-525-5p/spindle and kinetochore-associated complex subunit 1 (SKA1) axis regulates oxaliplatin resistance in breast cancer by activating the notch and Wnt signaling pathway. | Bioengineered | 2021 | 34288822 | PubTator, text mining | PubMed |
| Silencing of circHIPK3 Sensitizes Paclitaxel-Resistant Breast Cancer Cells to Chemotherapy by Regulating HK2 Through Targeting miR-1286. | Cancer Manag Res | 2021 | 34285578 | PubTator, text mining | PubMed |
| Targeting Protein Kinases Degradation by PROTACs. | Front Chem | 2021 | 34277564 | PubTator, text mining | PubMed |
| Current Molecular Biology and Therapeutic Strategy Status and Prospects for circRNAs in HBV-Associated Hepatocellular Carcinoma. | Front Oncol | 2021 | 34277444 | PubTator, text mining | PubMed |
| CDK10 in Gastrointestinal Cancers: Dual Roles as a Tumor Suppressor and Oncogene. | Front Oncol | 2021 | 34277407 | PubTator, text mining | PubMed |
| An Update on the Potential Roles of E2F Family Members in Colorectal Cancer. | Cancer Manag Res | 2021 | 34276228 | PubTator, text mining | PubMed |
| LncRNA HOXA-AS2 Promotes Tumor Progression by Suppressing miR-567 Expression in Oral Squamous Cell Carcinoma. | Cancer Manag Res | 2021 | 34267554 | PubTator, text mining | PubMed |
| Rac3 Expression and its Clinicopathological Significance in Patients With Bladder Cancer. | Pathol Oncol Res | 2021 | 34257551 | PubTator, text mining | PubMed |
| Methylation silencing CDH23 is a poor prognostic marker in diffuse large B-cell lymphoma. | Aging (Albany NY) | 2021 | 34252883 | PubTator, text mining | PubMed |
| Genomic Analysis Revealed Mutational Traits Associated with Clinical Outcomes in Osteosarcoma. | Cancer Manag Res | 2021 | 34234554 | PubTator, text mining | PubMed |
| MiR-382-5p suppresses M1 macrophage polarization and inflammatory response in response to bronchopulmonary dysplasia through targeting CDK8: Involving inhibition of STAT1 pathway. | Genes Cells | 2021 | 34228857 | PubTator, text mining | PubMed |
| Effect of vorinostat on INK4 family and HDACs 1, 2, and 3 in pancreatic cancer and hepatocellular carcinoma. | Res Pharm Sci | 2021 | 34221059 | PubTator, text mining | PubMed |
| NOP14 regulates the growth, migration, and invasion of colorectal cancer cells by modulating the NRIP1/GSK-3β/β-catenin signaling pathway. | Eur J Histochem | 2021 | 34218653 | PubTator, text mining | PubMed |
| Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer. | Pharmaceuticals (Basel) | 2021 | 34207383 | PubTator, text mining | PubMed |
| Targeting CDK9 for the Treatment of Glioblastoma. | Cancers (Basel) | 2021 | 34207158 | PubTator, text mining | PubMed |
| Evaluation of Somatic Mutations in Solid Metastatic Pan-Cancer Patients. | Cancers (Basel) | 2021 | 34204917 | PubTator, text mining | PubMed |
| Effects of a Novel Thiadiazole Derivative with High Anticancer Activity on Cancer Cell Immunogenic Markers: Mismatch Repair System, PD-L1 Expression, and Tumor Mutation Burden. | Pharmaceutics | 2021 | 34203761 | PubTator, text mining | PubMed |
| MicroRNA as a Novel Biomarker in the Diagnosis of Head and Neck Cancer. | Biomolecules | 2021 | 34198889 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1024/papers?page=35